Question 1

What is the catalog number for 3CLpro Protein (N-His & AVI, SARS-CoV-2)?

Accepted Answer

The catalog number for 3CLpro Protein (N-His & AVI, SARS-CoV-2) is P520628.

Question 2

What sizes are available for 3CLpro Protein (N-His & AVI, SARS-CoV-2)?

Accepted Answer

3CLpro Protein (N-His & AVI, SARS-CoV-2) is available in the following size(s): 100 µg.

Question 3

Is 3CLpro Protein (N-His & AVI, SARS-CoV-2) in stock?

Accepted Answer

3CLpro Protein (N-His & AVI, SARS-CoV-2) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Is this product tested for endotoxin levels?

Accepted Answer

Endotoxin testing status is noted on the datasheet where applicable, particularly for recombinant proteins intended for cell-based or functional assays. If this isn’t listed and you need confirmation, contact support with the catalogue number.

Question 5

Can I request additional validation data, such as western blot images, for this product?

Accepted Answer

Additional data may be available on request. Contact our technical support team with the catalogue number and we’ll check what supporting documentation the supplier can provide.

Question 6

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

3CLpro Protein (N-His & AVI, SARS-CoV-2)

Product Specifications

Abbreviation

Host

Tag

Purity

Function

Molecular Weight

Species

Frequently Asked Questions

Explore Other Products

AMACR / p504S (Prostate Cancer Marker) (AMACR/2748R), CF405S conjugate, 0.1mg/mL

Leonurine Hydrochloride

Frozen Tissue Blocks, Colon

Elab Fluor® 488 Anti-Rat CD4 (domain 1) Antibody[OX-38]

Elab Fluor® 488 Anti-Rat CD4 (domain 1) Antibody[OX-38]

Elab Fluor® 488 Anti-Rat CD4 (domain 1) Antibody[OX-38]